ORANGE, Calif. (February 18, 2026) — Today, the CalOptima Health Board of Directors released the findings of an independent investigation it authorized into certain expenditures made during the period when former Supervisor Andrew Do served on the Board of Directors, which found no evidence of fraud. Board counsel retained Ankura Consulting Group, LLC, an independent consulting firm, to ensure there was no wrongdoing in the use of CalOptima Health funds and to demonstrate its commitment to transparency, accountability, and turning the page on a challenging chapter in County and CalOptima Health governance.
The analysis conducted by Ankura evaluated expenditures from January 2011 to December 2024, which includes the period during which Andrew Do served as a member and as the Chair of the CalOptima Health Board of Directors. Investigators assessed whether the documents complied with CalOptima Health policies and procedures related to conflicts of interest, vendor contracting and participation in community events sponsored by external entities. Investigators also reviewed email communications between Do and CalOptima Health staff related to the expenditures and potential relationships with vendors.
The inquiry found that Do participated in discussions and votes with the CalOptima Health Board regarding organizations with which he may have had relationships, without properly disclosing his potential conflicts of interest. CalOptima Health has strengthened processes for identifying and managing conflicts of interest for CalOptima Health Board members and staff. The opportunities to improve process compliance identified in the Ankura report echo the comprehensive review by the California State Auditor (CSA) released in 2023. The CSA report recommended seven actions, which CalOptima Health immediately and successfully implemented to strengthen operations in support of our mission to serve members…